Histopathological patterns of renal diseases in Egyptian children : a single-center experience

Abstract EN

The present cross-sectional, retrospective study was aimed to determine the histopathological spectrum of renal diseases in Egyptian children and to evaluate the indications, safety, and efficacy of percutaneous renal biopsy (PRB) in a large tertiary center in Egypt.

PRBs performed at the Department of Pediatrics, Tanta University Hospital over a period of nine years (from January 2007 to December 2015) were included.

Light microscopic (LM) examination was performed in all cases while immunofluorescence and electron microscopic examination were performed in selected cases.

Two hundred and thirty renal biopsies were performed during the study duration.

Nine biopsies were excluded from the study due to insufficient sample (<7 glomeruli per specimen) giving a PRB efficacy rate of 96.

1 %.

Results of 221 renal biopsies performed on 210 patients from native kidneys were described.

Ninety-seven patients were male (46.19%) and 113 were female (53.81%) with age ranging from three months to 18 years (mean 10.51 ± 3.81 years).

The main indications of renal biopsy were nephrotic syndrome (NS) (43.89%), lupus nephritis (23.53 %), and recurrent or persistent hematuria (10.41 %).

The most common finding on LM examination of renal biopsies from children with NS was minimal change disease (22.17 %).

Secondary nephropathies were mostly due to lupus (23.53 %).

IgA nephropathy was found in eight patients (3.62 %).

Local pain at the site of biopsy was the most common minor complication seen postbiopsy (60.58%).

Transient gross hematuria was seen in 13 patients (5.88 %) without urinary retention.

Major complications that required surgical intervention or blood transfusion did not occur.

NS was the main indication and minimal change disease was the most common histological finding of renal biopsies from Egyptian children.

Complications and efficacy of renal biopsy procedure were comparable to that reported from developed countries.